These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21687737)

  • 1. 3, 3'5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements.
    Sar P; Peter R; Rath B; Das Mohapatra A; Mishra SK
    PLoS One; 2011; 6(6):e20861. PubMed ID: 21687737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of senescence marker protein-30 gene promoter: identification of repressor elements and functional nuclear factor binding sites.
    Rath B; Pandey RS; Debata PR; Maruyama N; Supakar PC
    BMC Mol Biol; 2008 Apr; 9():43. PubMed ID: 18442420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen.
    Scott GK; Marden C; Xu F; Kirk L; Benz CC
    Mol Cancer Ther; 2002 Apr; 1(6):385-92. PubMed ID: 12477051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sp1-mediated epigenetic dysregulation dictates HDAC inhibitor susceptibility of HER2-overexpressing breast cancer.
    Li G; Xie Q; Yang Z; Wang L; Zhang X; Zuo B; Zhang S; Yang A; Jia L
    Int J Cancer; 2019 Dec; 145(12):3285-3298. PubMed ID: 31111958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression.
    Guigon CJ; Kim DW; Zhu X; Zhao L; Cheng SY
    Endocrinology; 2010 Nov; 151(11):5528-36. PubMed ID: 20844001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
    Carr FE; Tai PW; Barnum MS; Gillis NE; Evans KG; Taber TH; White JH; Tomczak JA; Jaworski DM; Zaidi SK; Lian JB; Stein JL; Stein GS
    Endocrinology; 2016 Aug; 157(8):3278-92. PubMed ID: 27253998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms that mediate negative regulation of the thyroid-stimulating hormone alpha gene by the thyroid hormone receptor.
    Tagami T; Park Y; Jameson JL
    J Biol Chem; 1999 Aug; 274(32):22345-53. PubMed ID: 10428804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen.
    Jang ER; Lim SJ; Lee ES; Jeong G; Kim TY; Bang YJ; Lee JS
    Oncogene; 2004 Mar; 23(9):1724-36. PubMed ID: 14676837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
    Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
    Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells.
    Sharma P; Kumar S; Kundu GC
    Mol Cancer; 2010 Jul; 9():178. PubMed ID: 20609221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell type-specific roles of histone deacetylase in TR ligand-independent transcriptional repression.
    Lizcano F; Koibuchi N; Fukuda H; Dangond F; Chin WW
    Mol Cell Endocrinol; 2001 Feb; 172(1-2):13-20. PubMed ID: 11165035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down-regulating EGFR expression.
    Li J; Zhang T; Yang F; He Y; Dai F; Gao D; Chen Y; Liu M; Yi Z
    Br J Pharmacol; 2015 Aug; 172(15):3817-30. PubMed ID: 25884486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence.
    Perillo B; Sasso A; Abbondanza C; Palumbo G
    Mol Cell Biol; 2000 Apr; 20(8):2890-901. PubMed ID: 10733592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suberoylanilide hydroxamic acid-induced specific epigenetic regulation controls Leptin-induced proliferation of breast cancer cell lines.
    Feng X; Han H; Zou D; Zhou J; Zhou W
    Oncotarget; 2017 Jan; 8(2):3364-3379. PubMed ID: 27926517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC.
    Zhao ZN; Bai JX; Zhou Q; Yan B; Qin WW; Jia LT; Meng YL; Jin BQ; Yao LB; Wang T; Yang AG
    PLoS One; 2012; 7(9):e45133. PubMed ID: 23028803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
    Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
    Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
    Menendez JA; Vellon L; Lupu R
    Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
    Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
    Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.